ICON
ICON Public Limited Company is a global contract research organization that offers outsourced development services to the pharmaceutical, biotechnology, and medical device sectors. Established in 1990 and headquartered in Dublin, Ireland, ICON specializes in the strategic development, management, and analysis of programs that support all phases of the clinical development process, from compound selection to Phase I-IV clinical studies. The company provides a comprehensive range of services, including product development planning, clinical pharmacology, patient recruitment and retention, project management, and data management. Additionally, ICON offers ancillary services such as medical imaging, biostatistics, pharmacovigilance, and regulatory support. Its capabilities extend to adaptive and virtual trial services, as well as research trials for government agencies, making it a versatile partner for firms navigating the complexities of drug development and clinical trials.
Top Stages
21 past transactions
HumanFirst
Acquisition in 2024
HumanFirst is a company focused on enhancing patient-centered clinical trials through its advanced precision measures platform, which is recognized as the world's largest AI-powered software-as-a-service solution for improving health outcomes. The platform offers insights and validated evidence data to support biopharmaceutical companies in their drug development processes, enabling them to incorporate digital health technologies, digital biomarkers, and electronic clinical outcome assessments. By providing industry educational tools and facilitating collaboration with research partners, HumanFirst helps biopharma organizations increase research efficiency and accelerate the deployment of innovative treatments. The platform has been utilized by a significant majority of the largest pharmaceutical companies globally, underscoring its role in transforming clinical research and driving the evolution of drug development.
PRA Health Sciences
Acquisition in 2021
PRA Health Sciences, established in 1976 and headquartered in Raleigh, North Carolina, is a leading global contract research organization (CRO). It offers comprehensive outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. PRA's extensive services span clinical research, including product registration, early development, and strategic solutions, as well as data solutions such as market intelligence, consulting, and technology-enabled products. With over 17,000 employees across 90 offices in six continents, PRA has supported more than 3,800 clinical trials and contributed to the approval of over 85 products since 2000. The company is known for its commitment to excellence and high-quality global service.
Medpass International
Acquisition in 2020
MedPass International SAS, established in 1991 and headquartered in Paris, France, is a prominent medical device Contract Research Organization (CRO) specializing in regulatory affairs, reimbursement strategies, and clinical operations. As a subsidiary of ICON plc since 2020, MedPass offers strategic consulting, ER reimbursement support, biometrics services, legal representation, and data protection regulation assistance. The company's comprehensive suite of services caters to clients worldwide, facilitating the advancement of innovative medical device technologies across all development phases.
Accellacare
Acquisition in 2019
Accellacare is a clinical research organization that focuses on conducting clinical trials to evaluate the safety and efficacy of new medications. Formerly known as MeDiNova Research, Accellacare serves the pharmaceutical, biotechnology, and medical device industries by offering comprehensive trial services. The company emphasizes patient care, fostering a supportive environment for participants throughout the research process. With a strong emphasis on site network feasibility and centralized process management, Accellacare facilitates quicker study initiation. Additionally, its dedicated patient engagement team plays a crucial role in identifying and recruiting suitable participants through an extensive patient database and targeted outreach campaigns, leading to improved recruitment outcomes for clinical trials.
MolecularMD
Acquisition in 2019
MolecularMD Corporation specializes in developing and commercializing molecular diagnostics for oncology applications, focusing on tests that facilitate the selection, monitoring, and management of patients undergoing molecularly targeted cancer therapies. Founded in 2005 in Portland, Oregon, the company offers a range of services including assay design and development, clinical trial design, regulatory planning, clinical assay validation, and custom kit manufacturing. Its assays utilize a blend of established and innovative technologies, providing sensitive and reliable results that support the clinical development and regulatory approval of new cancer treatments. In addition to its headquarters in Oregon, MolecularMD operates a facility in Cambridge, Massachusetts, and is a subsidiary of ICON Laboratory Services Inc.
Mapi
Acquisition in 2017
Mapi is a prominent Patient-Centered Research company that has been serving academia, life science researchers, and the pharmaceutical industry for over 40 years. Founded in 1974, Mapi focuses on patient-centric research, engaging comprehensively with patients, healthcare providers, patient communities, payers, and regulators. The company offers a range of services, including Real-World Evidence, post-approval research, and consulting, aimed at addressing complex issues related to patient treatment. Mapi's commitment to advancing patient-focused methodologies has positioned it as a leader in the industry, facilitating the development of improved treatment processes and equipment for pharmaceutical companies. Its extensive experience and dedication to patient engagement underscore its role as a key contributor to the ongoing evolution of medical research.
Clinical Research Management
Acquisition in 2016
ClinicalRM is a full-service Contract Research Organization specializing in preclinical through Phase IV support of clinical research and clinical trial services for biologics, drugs and devices. The organization helps customers get their products to market faster with a wide array of research, regulatory and sponsor services within the U.S. and around the globe. From international partnerships and affiliations to government relations and local alliances, ClinicalRM delivers a synergy in the global market with projects spanning the government, academic and commercial marketplaces. The company has a distinct ability to provide boots-on-the-ground and rapid response efforts to global health crises.
PMG Research
Acquisition in 2015
PMG Research, Inc. is a clinical research organization based in Winston-Salem, North Carolina, specializing in conducting clinical trials across a wide range of therapeutic areas, including asthma, COPD, diabetes, cardiovascular diseases, and more. Founded in 1979, the company operates an integrated network of clinical research facilities located in multiple cities across the United States, including Tennessee, South Carolina, Illinois, and various locations within North Carolina. PMG Research has extensive experience, having conducted over 7,700 research studies for numerous pharmaceutical sponsors and contract research organizations. The company is dedicated to providing high-quality services to its clients and participants, supported by a team of skilled professionals and purpose-built research sites.
MediMedia Pharma Solutions
Acquisition in 2015
MediMedia Managed Markets provides you with the best strategic expertise available in the industry. Their large staff of managed markets strategists, researchers, MDs, PharmDs, and MPHs, all proven experts in the field, will help.
Aptiv Solutions
Acquisition in 2014
Aptiv Solutions, Inc. is a clinical research organization that specializes in providing a range of clinical trial services to biotechnology and pharmaceutical companies. The company offers adaptive trial design, simulation, and execution, as well as early phase development consulting and drug development services. In addition to these offerings, Aptiv Solutions provides regulatory compliance consulting, focusing on strategy development, agency advisory, legal representation, and submission management. The organization has therapeutic expertise in oncology, cardiology, dermatology, respiratory conditions, and orphan diseases. Aptiv Solutions also develops AptivAdvantage, an integrated technology platform designed for the implementation and execution of adaptive clinical trials. Founded in 1983 and based in Reston, Virginia, the company has an additional office in Durham, North Carolina. It was formerly known as Averion International Corp. before rebranding in February 2011.
Cross Country Healthcare
Acquisition in 2013
Cross Country Healthcare is a prominent provider of staffing and workforce solutions specifically tailored for the healthcare industry. The company specializes in total talent management services, which encompass strategic workforce solutions, contingent staffing, permanent placement, and advisory services to address various labor-related challenges. It operates primarily through two business segments: the nurse and allied staffing segment, which accounts for the majority of its revenue, focuses on the temporary and permanent placement of travel and local nurses and allied health professionals, along with outsourcing services. The Physician Staffing segment supplies licensed practitioners across a wide range of specialties, including certified registered nurse anesthetists, nurse practitioners, and physician assistants. Through its comprehensive offerings, Cross Country Healthcare aims to assist healthcare organizations in effectively managing their staffing needs.
PriceSpective
Acquisition in 2012
PriceSpective is a value strategy consultancy that defines, drives, and captures value for pharmaceutical and biotechnology clients in today's complex healthcare environment. The company delivers expert guidance in integrated global pricing, reimbursement and market access strategy with its depth of experience and actively engaged senior leadership. PriceSpective is headquartered in Philadelphia with offices in London, Los Angeles, San Diego, Raleigh and Boston.
BeijingWits Medical Consulting
Acquisition in 2011
Beijing Wits Medical Consulting Company was founded in 1997. The company provides services to global and local pharmaceutical, medical device and biotechnology companies focusing on Phase I to IV Clinical studies. Beijing Wits currently has more than 100 employees, operating from 6 offices in China.
Firecrest Clinical
Acquisition in 2011
Firecrest Clinical Ltd is a provider of site performance management solutions specifically designed for the pharmaceutical, biotechnology, and medical device industries. The company focuses on enhancing compliance and consistency within clinical trials by offering clinical investigator training and comprehensive study services. By delivering outsourced development services, Firecrest Clinical aims to support pharma companies in optimizing their clinical research processes, thereby improving overall site performance and ensuring adherence to regulatory standards.
Oxford Outcomes
Acquisition in 2011
Oxford Outcomes is a company that specializes in health outcomes research and consultancy services. It focuses on patient reported outcomes (PRO), health economics, epidemiology, and translation and linguistic validation. By offering these expert services, Oxford Outcomes aims to enhance the understanding of health-related quality of life and improve decision-making in healthcare. The company's work is essential for stakeholders seeking to evaluate the effectiveness of medical treatments and interventions through the lens of patient experiences and outcomes.
Timaq Medical Imaging
Acquisition in 2010
Timaq Medical Imaging is a Swiss-based company that specializes in advanced medical imaging services tailored for the pharmaceutical and biotech industries. It provides essential support for clinical trials that involve medical imaging, helping firms navigate the complexities of study design and execution. By offering expertise in imaging techniques, Timaq facilitates the evaluation of drug efficacy and safety, thereby playing a crucial role in the development of new therapies. The company's services are designed to meet the specific needs of its clients in the contract service sector, ensuring high-quality imaging solutions that contribute to the advancement of medical research.
Veeda Laboratories
Acquisition in 2009
Veeda Laboratories Ltd is a specialist provider of biomarker laboratory services to global pharmaceutical and biotechnology industries.
Prevalere Life Sciences
Acquisition in 2008
Prevalere Life Sciences, Inc. is a contract research organization that specializes in providing bio-analytical and immunoassay laboratory services. The company offers a range of services including GLP/cGMP compliant analytical testing, chemical analysis, and data analysis. It primarily serves clients in the pharmaceutical and biotechnology industries, delivering reliable analytical and testing solutions to support their research and development efforts. In addition, Prevalere Life Sciences provides offsite staffing solutions and other related services to meet the diverse needs of its clientele.
Barton & Polansky Associates
Acquisition in 2002
Barton & Polansky Associates, Inc is specialises in clinical research services for immuno-suppressant drugs.
UCT (U.S.)
Acquisition in 2000
UCT (U.S.), Inc provides central laboratory services for clinical trials to the pharmaceutical and biotechnology industries.
Pacific Research Associates
Acquisition in 2000
Pacific Research Associates, Inc is specialising in data management statistical analysis and medical and regulatory consulting.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.